Back to JANX
D. E. Shaw & Co., Inc. JANX Position History
Janux Therapeutics, Inc. • Healthcare
Quarters held
7
Latest value
$16.8M
Q2 2026
Peak value
$16.8M
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $2.1M |
| Q2 2024 | $4.1M |
| Q3 2024 | $3.8M |
| Q4 2025 | $451K |
| Q1 2026 | $572K |
| Q1 2026 | $795K |
| Q2 2026 | $16.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $16.8M | 1.10M | — | — |
| Q1 2026 | $795K | 57.2K | — | — |
| Q1 2026 | $572K | 41.2K | — | — |
| Q4 2025 | $451K | 32.7K | — | — |
| Q3 2024 | $3.8M | 84.0K | — | — |
| Q2 2024 | $4.1M | 97.8K | — | — |
| Q1 2024 | $2.1M | 54.6K | — | — |